Home › Companies › KORRO BIO INC. › 2024-2025

KORRO BIO INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and KORRO BIO INC.’s Form 8-K, filed June 11, 2025 (Item 5.07 on EDGAR). Page generated November 1, 2026.

  • 6Reported items
  • 112Asset managers
  • 853Fund votes
  • June 11, 2025Meeting date

Results at a glance

Meeting of June 11, 2025: 5 items on KORRO BIO INC.’s Form 8-K, filed June 11, 2025: 3 elected · 2 approved.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025 2025-2026

Explore KORRO BIO INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by KORRO BIO INC.

These tallies are KORRO BIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 11, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

KORRO BIO INC. — official shareholder meeting results, meeting held June 11, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Ram Aiyar 7,979,072---- 18,461360,141 99.7%Elected—
Elect Director: Jean-François Formela 4,986,043---- 3,011,490360,141 62%Elected—
Elect Director: Katharine Knobil 7,980,056---- 17,477360,141 99.7%Elected—
Proposal 2: Korro's stockholders approved, in a non-binding, advisory vote, the compensation of Korro's named executive officers. 7,972,38913,99911,145 --360,141 99.8%Approved—
Proposal 4: Korro's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2025. 8,342,6238,3696,682 --0 99.8%Approved—

Source: KORRO BIO INC., Form 8-K, filed with the SEC on June 11, 2025 — read the filing on EDGAR.

How asset managers voted at the KORRO BIO INC. 2024-2025 meeting

Each item below shows how the 112 asset managers that disclosed a KORRO BIO INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of KORRO BIO INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Jean-François Formela

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

62% Majority: yes · of votes cast

FOR 62%WITHHELD
FOR: 4,986,043WITHHELD: 3,011,490
Details: description as filed, official tally, votes by 36 asset managers

Description as filed by funds: Election of three Class III directors nominated by our board of directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Jean-Francois Formela

KORRO BIO INC.’s own tally for this item (“Elect Director: Jean-François Formela”): 4,986,043 for, 3,011,490 withheld, per its Form 8-K filed June 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “1) Korro's stockholders elected each of Ram Aiyar, Jean-François Formela and Katharine Knobil as Class III directors, each for a three-year term ending at the annual meeting of stockholders to be held in 2028 and each until his or her respective successor has been duly elected and qualified or unti…”
Support: 62% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 36 asset managers below reported 312,897 for, 835,584 withheld.

FORWITHHOLD
FOR: 312,897WITHHOLD: 835,584
Largest asset managers voting on “Election of three Class III directors nominated by our board of directors, each to serve for a three-year term” at KORRO BIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
AllianceBernstein00 0375,168Withhold
Fidelity76,2920 0224,750Mixed
Vanguard180,5960 00For
Aberdeen00 084,428Withhold
Principal00 072,398Withhold
FRANKLIN STRATEGIC SERIES33,8000 00For
Charles Schwab18,2880 00For
DRIEHAUS MUTUAL FUNDS00 013,195Withhold
QUANTITATIVE MASTER SERIES LLC00 09,641Withhold
RBB FUND, INC.00 07,282Withhold
Brighthouse00 05,699Withhold
Northern Trust00 05,428Withhold
Equitable00 05,332Withhold
Lincoln Financial00 04,500Withhold
BlackRock00 04,063Withhold
Brinker Capital Destinations Trust00 03,812Withhold
Global X3,5900 00For
AIG/SunAmerica00 03,147Withhold
Pacific Life00 03,029Withhold
Bridge Builder Trust00 02,361Withhold
John Hancock00 02,281Withhold
American Century00 01,998Withhold
Meeder Funds00 01,931Withhold
ProShares00 01,018Withhold
DWS00 0966Withhold

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

2. Elect Director: Katharine Knobil

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 7,980,056WITHHELD: 17,477
Details: description as filed, official tally, votes by 36 asset managers

Description as filed by funds: Election of three Class III directors nominated by our board of directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Katharine Knobil

KORRO BIO INC.’s own tally for this item (“Elect Director: Katharine Knobil”): 7,980,056 for, 17,477 withheld, per its Form 8-K filed June 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “1) Korro's stockholders elected each of Ram Aiyar, Jean-François Formela and Katharine Knobil as Class III directors, each for a three-year term ending at the annual meeting of stockholders to be held in 2028 and each until his or her respective successor has been duly elected and qualified or unti…”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 36 asset managers below reported 1,142,783 for, 5,698 withheld.

FOR
FOR: 1,142,783WITHHOLD: 5,698
Largest asset managers voting on “Election of three Class III directors nominated by our board of directors, each to serve for a three-year term” at KORRO BIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
AllianceBernstein375,1680 00For
Fidelity301,0420 00For
Vanguard180,5960 00For
Aberdeen84,4280 00For
Principal72,3980 00For
FRANKLIN STRATEGIC SERIES33,8000 00For
Charles Schwab18,2880 00For
DRIEHAUS MUTUAL FUNDS13,1950 00For
QUANTITATIVE MASTER SERIES LLC9,6410 00For
RBB FUND, INC.7,2820 00For
Brighthouse10 05,698Withhold
Northern Trust5,4280 00For
Equitable5,3320 00For
Lincoln Financial4,5000 00For
BlackRock4,0630 00For
Brinker Capital Destinations Trust3,8120 00For
Global X3,5900 00For
AIG/SunAmerica3,1470 00For
Pacific Life3,0290 00For
Bridge Builder Trust2,3610 00For
John Hancock2,2810 00For
American Century1,9980 00For
Meeder Funds1,9310 00For
ProShares1,0180 00For
DWS9660 00For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

3. Elect Director: Ram Aiyar

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 7,979,072WITHHELD: 18,461
Details: description as filed, official tally, votes by 36 asset managers

Description as filed by funds: Election of three Class III directors nominated by our board of directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Ram Aiyar

KORRO BIO INC.’s own tally for this item (“Elect Director: Ram Aiyar”): 7,979,072 for, 18,461 withheld, per its Form 8-K filed June 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “1) Korro's stockholders elected each of Ram Aiyar, Jean-François Formela and Katharine Knobil as Class III directors, each for a three-year term ending at the annual meeting of stockholders to be held in 2028 and each until his or her respective successor has been duly elected and qualified or unti…”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 36 asset managers below reported 1,142,185 for, 6,296 withheld.

FOR
FOR: 1,142,185WITHHOLD: 6,296
Largest asset managers voting on “Election of three Class III directors nominated by our board of directors, each to serve for a three-year term” at KORRO BIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
AllianceBernstein375,1680 00For
Fidelity301,0420 00For
Vanguard180,5960 00For
Aberdeen84,4280 00For
Principal72,3980 00For
FRANKLIN STRATEGIC SERIES33,8000 00For
Charles Schwab18,2880 00For
DRIEHAUS MUTUAL FUNDS13,1950 00For
QUANTITATIVE MASTER SERIES LLC9,6410 00For
RBB FUND, INC.7,2820 00For
Brighthouse10 05,698Withhold
Northern Trust5,4280 00For
Equitable5,3320 00For
Lincoln Financial4,5000 00For
BlackRock4,0630 00For
Brinker Capital Destinations Trust3,8120 00For
Global X3,5900 00For
AIG/SunAmerica3,1470 00For
Pacific Life3,0290 00For
Bridge Builder Trust2,3610 00For
John Hancock2,2810 00For
American Century1,9980 00For
Meeder Funds1,9310 00For
ProShares1,0180 00For
DWS9660 00For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

4. Proposal 2: Korro's stockholders approved, in a non-binding, advisory vote, the compensation of Korro's named executive…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

99.8% Approved · of votes cast

FOR 99.8%
FOR: 7,972,389AGAINST: 13,999
Details: description as filed, official tally, votes by 112 asset managers

Description as filed by funds: Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers;

KORRO BIO INC.’s own tally for this item (“Proposal 2: Korro's stockholders approved, in a non-binding, advisory vote, the compensation of Korro's named executive officers.”): 7,972,389 for, 13,999 against — passed, per its Form 8-K filed June 11, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “2) Korro's stockholders approved, in a non-binding, advisory vote, the compensation of Korro's named executive officers.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 36 asset managers voting on “Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers;” at KORRO BIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
AllianceBernstein375,1680 00For
Fidelity301,0420 00For
Vanguard180,5960 00For
Aberdeen84,4280 00For
Principal72,3980 00For
FRANKLIN STRATEGIC SERIES33,8000 00For
Charles Schwab18,2880 00For
DRIEHAUS MUTUAL FUNDS13,1950 00For
QUANTITATIVE MASTER SERIES LLC9,6410 00For
RBB FUND, INC.7,2820 00For
Brighthouse10 5,6980Abstain
Northern Trust5,4280 00For
Equitable5,3320 00For
Lincoln Financial4,5000 00For
BlackRock4,0630 00For
Brinker Capital Destinations Trust3,8120 00For
Global X3,5900 00For
AIG/SunAmerica3,1470 00For
Pacific Life3,0290 00For
Bridge Builder Trust2,3610 00For
John Hancock2,2810 00For
American Century01,998 00Against
Meeder Funds1,9310 00For
ProShares1,0180 00For
DWS9660 00For

Fund voting reports, all 36 managers: 1,140,187 for, 2,596 against, 5,698 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 91 asset managers voting on “Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers;” at KORRO BIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Atlas Venture Life Science Advisors, LLC1,137,1490 00For
NEA Management Company, LLC1,092,1300 00For
Deep Track Capital, LP865,1860 00For
AllianceBernstein568,2400 00For
DRIEHAUS CAPITAL MANAGEMENT LLC545,6890 00For
Fidelity480,4180 00For
Qiming U.S. Ventures Management, LLC368,0850 00For
Siren, L.L.C.277,4520 00For
Cormorant Asset Management, LP243,3620 00For
Citadel228,7630 00For
GEODE CAPITAL MANAGEMENT, LLC92,1520 00For
FRANKLIN ADVISERS INC91,7040 00For
Aberdeen84,4280 00For
Point7274,2060 00For
BlackRock64,066230 00For
Ally Bridge Group (NY) LLC59,7230 00For
State Street56,41850 00For
Woodline Partners LP50,0940 00For
Tri Locum Partners LP49,8970 00For
DAFNA Capital Management LLC47,0860 00For
ADAR1 Capital Management, LLC34,8240 00For
ORBIMED ADVISORS LLC32,4000 00For
Charles Schwab24,3760 00For
Northern Trust24,2300 00For
BLAIR WILLIAM & CO/IL16,2260 00For

Institutional-manager reports, all 91 managers: 6,674,709 for, 4,463 against, 1,736 1 year. Showing the 25 largest; see all in the interactive database.

5. Non-Binding Advisory Vote on the Frequency of Future Non- Binding Advisory Votes to Approve the Compensation of our…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

99.9% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: description as filed, votes by 109 asset managers

Description as filed by funds: Non-Binding Advisory Vote on the Frequency of Future Non- Binding Advisory Votes to Approve the Compensation of our Named Executive Officers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 36 asset managers voting on “Non-Binding Advisory Vote on the Frequency of Future Non- Binding Advisory Votes to Approve the Compensation o” at KORRO BIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
AllianceBernstein00 00--
Fidelity00 00--
Vanguard00 00--
Aberdeen00 00--
Principal00 00--
FRANKLIN STRATEGIC SERIES00 00--
Charles Schwab00 00--
DRIEHAUS MUTUAL FUNDS00 00--
QUANTITATIVE MASTER SERIES LLC00 00--
RBB FUND, INC.00 00--
Brighthouse00 5,6980Abstain
Northern Trust00 00--
Equitable00 00--
Lincoln Financial00 00--
BlackRock00 00--
Brinker Capital Destinations Trust00 00--
Global X00 00--
AIG/SunAmerica00 00--
Pacific Life00 00--
Bridge Builder Trust00 00--
John Hancock00 00--
American Century00 00--
Meeder Funds00 00--
ProShares00 00--
DWS00 00--

Fund voting reports, all 36 managers: 5,698 abstained, 1,142,783 1 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 88 asset managers voting on “Non-Binding Advisory Vote on the Frequency of Future Non- Binding Advisory Votes to Approve the Compensation o” at KORRO BIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Atlas Venture Life Science Advisors, LLC00 00--
NEA Management Company, LLC00 00--
Deep Track Capital, LP00 00--
AllianceBernstein00 00--
DRIEHAUS CAPITAL MANAGEMENT LLC00 00--
Fidelity00 00--
Siren, L.L.C.00 00--
Cormorant Asset Management, LP00 00--
Citadel00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
FRANKLIN ADVISERS INC00 00--
Aberdeen00 00--
Point7200 00--
BlackRock00 00--
Ally Bridge Group (NY) LLC59,7230 00For
State Street00 00--
Woodline Partners LP00 00--
Tri Locum Partners LP00 00--
DAFNA Capital Management LLC00 00--
ADAR1 Capital Management, LLC00 00--
ORBIMED ADVISORS LLC00 00--
Charles Schwab00 00--
Northern Trust00 00--
BLAIR WILLIAM & CO/IL00 00--
MELLON INVESTMENTS Corp00 00--

Institutional-manager reports, all 88 managers: 61,776 for, 42 against, 6,242,331 1 year, 874 2 year, 2 3 year. Showing the 25 largest; see all in the interactive database.

6. Proposal 4: Korro's stockholders ratified the selection of Ernst & Young LLP as its independent registered public…

Official resultAUDIT-RELATEDReported outcome: Approved

99.8% Approved · of votes cast

FOR 99.8%
FOR: 8,342,623AGAINST: 8,369
Details: description as filed, official tally, votes by 36 asset managers

Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.

KORRO BIO INC.’s own tally for this item (“Proposal 4: Korro's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2025.”): 8,342,623 for, 8,369 against — passed, per its Form 8-K filed June 11, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4: Korro's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 36 asset managers below reported 1,142,783 for, 5,698 abstained.

FOR
FOR: 1,142,783ABSTAIN: 5,698
Largest asset managers voting on “Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for ” at KORRO BIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
AllianceBernstein375,1680 00For
Fidelity301,0420 00For
Vanguard180,5960 00For
Aberdeen84,4280 00For
Principal72,3980 00For
FRANKLIN STRATEGIC SERIES33,8000 00For
Charles Schwab18,2880 00For
DRIEHAUS MUTUAL FUNDS13,1950 00For
QUANTITATIVE MASTER SERIES LLC9,6410 00For
RBB FUND, INC.7,2820 00For
Brighthouse10 5,6980Abstain
Northern Trust5,4280 00For
Equitable5,3320 00For
Lincoln Financial4,5000 00For
BlackRock4,0630 00For
Brinker Capital Destinations Trust3,8120 00For
Global X3,5900 00For
AIG/SunAmerica3,1470 00For
Pacific Life3,0290 00For
Bridge Builder Trust2,3610 00For
John Hancock2,2810 00For
American Century1,9980 00For
Meeder Funds1,9310 00For
ProShares1,0180 00For
DWS9660 00For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

Largest KORRO BIO INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 9,390,492 shares outstanding at the time of that meeting.

Fund voting reports: top KORRO BIO INC. shareholders by shares voted on “Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers;”, 2024-2025
#Asset manager % of shares outstanding
1AllianceBernstein 4.00%
2Fidelity 3.21%
3Vanguard 1.92%
4Aberdeen 0.90%
5Principal 0.77%
6FRANKLIN STRATEGIC SERIES 0.36%
7Charles Schwab 0.19%
8DRIEHAUS MUTUAL FUNDS 0.14%
9QUANTITATIVE MASTER SERIES LLC 0.10%
10RBB FUND, INC. 0.08%
Institutional-manager reports: top KORRO BIO INC. shareholders by shares voted on “Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers;”, 2024-2025
#Asset manager % of shares outstanding
1Atlas Venture Life Science Advisors, LLC 12.11%
2NEA Management Company, LLC 11.63%
3Deep Track Capital, LP 9.21%
4AllianceBernstein 6.05%
5DRIEHAUS CAPITAL MANAGEMENT LLC 5.81%
6Fidelity 5.12%
7Qiming U.S. Ventures Management, LLC 3.92%
8Siren, L.L.C. 2.95%
9Cormorant Asset Management, LP 2.59%
10Citadel 2.44%

Reported KORRO BIO INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

KORRO BIO INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
Lynx1 Capital Management LP 16.38% 13G
Venrock Healthcare Capital Partners III, L.P. 15.85% 13G
New Enterprise Associates 17, L.P. 15.29% 13D
Steven A. Cohen 8.70% 13G
FMR (Fidelity) 6.85% 13F
Point72 5.55% 13F
BlackRock 4.70% 13F
Vanguard Group 4.07% 13F
Citadel Advisors 2.70% 13F
Geode Capital 1.49% 13F

Percentages above are of 9,390,492 shares outstanding, as reported by KORRO BIO INC. on its Form 10-Q dated May 5, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from KORRO BIO INC.’s 10-Q dated May 5, 2025. This page is a static snapshot rebuilt weekly on November 1, 2026; a live search always shows the current data.

At KORRO BIO INC.'s shareholder meeting held June 11, 2025, in the 2024-2025 proxy season, 112 asset managers reported how they voted in their SEC Form N-PX filings, covering 853 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers; — KORRO BIO INC.'s filing reports the proposal as approved, with 99.8% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: KORRO BIO INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 11, 2025.

KORRO BIO INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.